The National Institutes of Health (NIH) has begun enrolling participants in a clinical trial to test the effectiveness of hydroxychloroquine in treating COVID-19, the agency announced Thursday.

NIH Clinical Center in Bethesda, Md. NIH. By Jonathan Wosen and Jason Mast. May 6, 2025. Jonathan Wosen [email protected] Jonathan Wosen is STAT’s West Coast biotech & life sciences reporter.

The NIH Clinical Center — the nation’s largest hospital devoted solely to medical research — is in crisis. In 2023, the hospital ran around 1,500 studies with a permanent staff of more than ...

NIH clinical trial will test precision medicine treatments for myeloid cancers NOTE: A virtual media briefing is scheduled for Tuesday, October 22, 2024, at 11:30 a.m. ET. Details below.

A clinical trial supported by the National Institutes of Health (NIH) is testing an experimental treatment designed to help people suffering the effects of dengue, a mosquito-borne viral disease.

A Phase 1 clinical trial of a novel influenza vaccine has begun inoculating healthy adult volunteers at the National Institutes of Health Clinical Center in Bethesda, Maryland. The placebo ...

A clinical trial to test the safety, tolerability and efficacy of a combination treatment regimen for coronavirus disease 2019 (COVID-19) consisting of the antiviral remdesivir plus a highly ...

BETHESDA, Md., Oct. 23, 2024 /PRNewswire/ -- The National Institutes of Health (NIH) has launched a proof-of-concept precision medicine clinical t Tuesday, 02 January 2024 12:17 GMT عربي ...

The NIH's National Institute of General Medical Sciences is providing $11.7 million, which will be matched by UofL, to launch the Louisville Clinical and Translational Research Center.

Campbell works at the NIH Clinical Center in Bethesda, Maryland. The award recognized his work The Testing and Diagnostics Working Group, which is part of the Health and Human Services COVID-19 ...

NIH begins large clinical trial to test immune modulators for treatment of COVID-19. Accessed October 16, 2020. Disclosures: Collins reports no relevant financial disclosures.

A collaboration between Transgenomic and the University of Nebraska Medical Center researchers have won a $100,000 Phase I Small Business Technology Transfer Program (STTR) grant from NIH’s ...